Overview
- 36 inspections across 36 sites are on record.
- 2 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2019-06-20.
At a glance
Inspections
36
Sites
36
Observations
2
Career since
May 2009
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Octapharma Plasma, Inc. | 20 Jun 2019 | Biologics | |
| Kedplasma LLC | 6 Jun 2019 | Biologics | |
| Octapharma Plasma Inc | 10 May 2019 | Biologics | |
| Biomat USA Inc | 6 Mar 2019 | Biologics | |
| CSL Plasma Inc. | 29 Nov 2018 | Biologics | On file |
Sites inspected
Octapharma Plasma, Inc.West Covina, United States1 insp.
Kedplasma LLCPharr, United States1 insp.
Octapharma Plasma IncOakland, United States1 insp.
Biomat USA IncChicago, United States1 insp.
CSL Plasma Inc.Longwood, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Angel F Colon2 shared
Judy E Ciaraldi2 shared
Barbara G Peoples2 shared
Adam J Taylor1 shared
Yvonne C Wilkes1 shared
Leeterry Moore1 shared
Barbara T Carmichael1 shared
Cody D Rickman1 shared
Marlene L Davis1 shared
Kanaeko R Ravenell1 shared
Full investigator report
Get the verbatim findings behind Hoimay Chan's 2 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site